Insulin resistance and diabetes in the context of treatment of hypertension

Blood Pressure

Volumn 7, Issue SUPPL. 3, 1998, Pages 28-31

  Lithell, Hans O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

antihypertensive treatment; hyperinsulinemia; hypertension; insulin resistance

Indexed keywords

ANTIHYPERTENSIVE AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; GLUCOSE; IMIDAZOLINE 1 RECEPTOR AGONIST; INSULIN; LISINOPRIL; MOXONIDINE; PRAZOSIN; UNCLASSIFIED DRUG;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN CELL; HUMAN TISSUE; INSULIN SENSITIVITY; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INSULIN RESISTANCE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 0032457852     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/080370598438456     Document Type: Article

References (28)

1. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet 1997; 350 (Suppl I): 4-9. (Pubitemid 127673449)
2. Rubin JR, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78: 809A-F. (Pubitemid 24986633)
3. Stamler J, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 433-44.
4. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predicts coronary heart disease in elderly patients. Diabetes 1994; 43: 960-7. (Pubitemid 24230698)
5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607. (Pubitemid 19004941)
6. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
7. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-81. (Pubitemid 26049592)
8. Julius S, Gudbrandsson T, Majersson K, Andersson O. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Press 1992; 1: 9-19.
9. Bengtsson C, Blohmé G, Lapidus L, Lundgren H. Diabetes in hypertensive women: an effect of antihypertensive drugs or the hypertensive state per se? Diabetes Med 1988; 5: 261-4.
10. Skarfors ET, Selinus KI, Lithell HO. Risk factors for development of non-insulin-dependent diabetes in middle-aged men. Results from a 10-year follow-up of participants in an Uppsala health survey. BMJ 1991; 303: 755-60.
11. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M, Haffner SM. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 1994; 12: 1425-32.
12. Lithell H, Pollare T, Vessby B. Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. Blood Press 1992; 1: 92-101.
13. Haenni A, Lithell H. Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension. Metabolism 1994; 43: 455-61. (Pubitemid 24113166)
14. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double-blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 1989; 298: 1152-7. (Pubitemid 19121350)
15. Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989; 7: 551-9. (Pubitemid 19189577)
16. Lind L, Berne C, Pollare T, Lithell H. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study. J Hum Hypertens 1995; 9: 137-41.
17. Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens 1991; 4: 199-205.
18. Lind L, Berne C, Pollare T, Lithell H. Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment. J Intern Med 1994; 236: 37-42. (Pubitemid 24227925)
19. Pollare T, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988; 31: 415-20.
20. Andersson PE, Johansson J, Berne C, Lithell H. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens 1994; 8: 219-26. (Pubitemid 24090280)
21. Andersson P-E, Lithell H. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow. Am J Hypertens: in press.
22. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-73. (Pubitemid 19238619)
23. Reneland R, Andersson P-E, Hänni A, Lithell H. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition. Eur J Clin Pharmacol 1994; 46: 431-6. (Pubitemid 24199204)
24. Hänni A, Andersson PE, Lind L, Lithell H. Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens 1994; 7: 615-22. (Pubitemid 24265157)
25. Ollivier J-P, Christen MO. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience. J Cardiovasc Pharmacol 1994; 24 (Suppl): S39-48. (Pubitemid 24357076)
26. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 2: 419-23. (Pubitemid 19168223)
27. Lithell H. Pathogenesis and prevalence of atherosclerosis in hypertensive patients. Am J Hypertens 1994; 7: 2S-6S. (Pubitemid 24248707)
28. Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-7.